Skip to content

Effects of driving pressure target-controlled positive end-expiratory pressure ventilation on respiratory mechanics and intrapulmonary shunt in elderly patients undergoing laparoscopic cholecystectomy

Effects of driving pressure target-controlled positive end-expiratory pressure ventilation on respiratory mechanics and intrapulmonary shunt in elderly patients undergoing laparoscopic cholecystectomy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037249
Enrollment
Unknown
Registered
2020-08-27
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

elderly patients undergoing laparoscopic cholecystectomy

Interventions

standard PEEP:standard PEEP
Driving pressure target-controlled PEEP:Driving pressure target-controlled PEEP

Sponsors

Meirong Yang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients were approached by study staff and were eligible if they: (1) are aged from 65 to 80 years old; (2) had an American Society of Anesthesiology Physical Status score of I~II grade; and (3) 18kg/m2 <= BMI <= 30kg/m2; (4) planned for laparoscopic cholecystectomy.

Exclusion criteria

Exclusion criteria: (1) those who refused to participate in the experiment and did not sign the informed consent form; (2) the patients had symptoms of upper respiratory tract infection or pulmonary infection in the past 4 weeks. Or Chest X-ray showed pneumonia; (3) diseases affecting thoracic and pulmonary compliance, such as chicken chest, funnel chest, chest trauma and surgery, chronic obstructive emphysema, pleural effusion and acute respiratory distress syndrome; (4) history of neuromuscular dysfunction; (5) serious cardiovascular events, lung, kidney and hematopoietic system diseases; (6) patients who had received general anesthesia in the first 7 days at random; (7) patients with mental system diseases and cognitive impairment, and patients with previous history of psychotropic and narcotic substance abuse; (8) other conditions in which the researchers determined that the patient was not suitable to participate in the clinical trial.

Design outcomes

Primary

MeasureTime frame
Respiratory mechanics index;Blood gas and oxygenation index;

Countries

China

Contacts

Public ContactMeirong Yang

Shanghai General Hospital

yangmr2005@126.com+86 18101873536

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026